Haloperidol in palliative care: Indications and risks
Individual response to medication depends on several factors (age, gender, body weight, general clinical condition, genetics, diet, hydration status, comorbidities, co-administered drugs and their mode of administration, smoking, alcohol overuse, environmental factors, e.g. sunlight) that may contri...
Main Authors: | Iwona Zaporowska-Stachowiak, Katarzyna Stachowiak-Szymczak, Mary-Tiffany Oduah, Maciej Sopata |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220309653 |
Similar Items
-
Midazolam: Safety of use in palliative care
by: Iwona Zaporowska-Stachowiak, et al.
Published: (2019-06-01) -
Midazolam and hydroxymidazolam plasma concentrations can be monitored with selected biochemical and physiological parameters of palliative care patients
by: Iwona Zaporowska-Stachowiak, et al.
Published: (2021-05-01) -
Determination of compatibility and stability of haloperidol and morphine mixtures used in palliative care
by: Espinosa Bosch María, et al.
Published: (2018-07-01) -
Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
by: Marek Krzystanek, et al.
Published: (2020-12-01) -
An adverse drug interaction of haloperidol with levodopa
by: Jisha M Lucca, et al.
Published: (2015-01-01)